169 related articles for article (PubMed ID: 21468688)
1. High acute myeloid leukemia derived VEGFA levels are associated with a specific vascular morphology in the leukemic bone marrow.
Weidenaar AC; ter Elst A; Koopmans-Klein G; Rosati S; den Dunnen WF; Meeuwsen-de Boer T; Kamps WA; Vellenga E; de Bont ES
Cell Oncol (Dordr); 2011 Aug; 34(4):289-96. PubMed ID: 21468688
[TBL] [Abstract][Full Text] [Related]
2. Lactate dehydrogenase, not vascular endothelial growth factor or basic fibroblast growth factor, positively correlates to bone marrow vascularity in acute myeloid leukemia.
Teng CL; Young JH; Hsu SL; Chou G; Kuo IT; Yu CY; Hwang GY
J Chin Med Assoc; 2006 Nov; 69(11):534-7. PubMed ID: 17116616
[TBL] [Abstract][Full Text] [Related]
3. [Dynamic observation of vascular endothelial growth factor (VEGF)/VEGF-receptors expression in acute leukemia].
Wang C; Chen FY; Zhu JS; Xu YP; Han JY; Ouyang RR
Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):845-8. PubMed ID: 15634546
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
[TBL] [Abstract][Full Text] [Related]
5. SEMA3A partially reverses VEGF effects through binding to neuropilin-1.
Palodetto B; da Silva Santos Duarte A; Rodrigues Lopes M; Adolfo Corrocher F; Roversi FM; Soares Niemann F; Priscila Vieira Ferro K; Leda Figueiredo Longhini A; Melo Campos P; Favaro P; Teresinha Olalla Saad S
Stem Cell Res; 2017 Jul; 22():70-78. PubMed ID: 28636974
[TBL] [Abstract][Full Text] [Related]
6. Evidence of increased angiogenesis in patients with acute myeloid leukemia.
Hussong JW; Rodgers GM; Shami PJ
Blood; 2000 Jan; 95(1):309-13. PubMed ID: 10607717
[TBL] [Abstract][Full Text] [Related]
7. CD147 and VEGF co-expression predicts prognosis in patients with acute myeloid leukemia.
Fu J; Fu J; Chen X; Zhang Y; Gu H; Bai Y
Jpn J Clin Oncol; 2010 Nov; 40(11):1046-52. PubMed ID: 20558462
[TBL] [Abstract][Full Text] [Related]
8. [Protein and mRNA expression of CTGF, CYR61, VEGF-C and VEGFR-2 in bone marrow of leukemia patients and its correlation with clinical features].
He QT; Bai XQ; Liu XW; Xu N; Lu Y; Zhang DX; Li J; Yun Y; Li ZQ; Han HY; Han XM; Ma HJ; Zhao ZY; Jia GR; Li Z; Yuan XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):653-9. PubMed ID: 24989271
[TBL] [Abstract][Full Text] [Related]
9. Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor.
de Bont ES; Rosati S; Jacobs S; Kamps WA; Vellenga E
Br J Haematol; 2001 May; 113(2):296-304. PubMed ID: 11380392
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
11. Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemia.
Liersch R; Schliemann C; Bieker R; Hintelmann H; Buechner T; Berdel WE; Mesters RM
Leuk Res; 2008 Jun; 32(6):954-61. PubMed ID: 18006056
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-Inducible Factor1-Α (HIF1α) and Vascular Endothelial Growth Factor-A (VEGF-A) Expression in De Novo AML Patients.
Jabari M; Allahbakhshian Farsani M; Salari S; Hamidpour M; Amiri V; Mohammadi MH
Asian Pac J Cancer Prev; 2019 Mar; 20(3):705-710. PubMed ID: 30909668
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia.
Padró T; Bieker R; Ruiz S; Steins M; Retzlaff S; Bürger H; Büchner T; Kessler T; Herrera F; Kienast J; Müller-Tidow C; Serve H; Berdel WE; Mesters RM
Leukemia; 2002 Jul; 16(7):1302-10. PubMed ID: 12094254
[TBL] [Abstract][Full Text] [Related]
14. Coculture of native human acute myelogenous leukemia blasts with fibroblasts and osteoblasts results in an increase of vascular endothelial growth factor levels.
Glenjen NI; Hatfield K; Bruserud Ø
Eur J Haematol; 2005 Jan; 74(1):24-34. PubMed ID: 15613103
[TBL] [Abstract][Full Text] [Related]
15. [Angiogenesis in patients with hematologic malignancies].
Mesters RM; Padró T; Steins M; Bieker R; Retzlaff S; Kessler T; Kienast J; Berdel WE
Onkologie; 2001 Sep; 24 Suppl 5():75-80. PubMed ID: 11600818
[TBL] [Abstract][Full Text] [Related]
16. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.
Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
[TBL] [Abstract][Full Text] [Related]
17. GVHD after allogeneic haematopoietic SCT for AML: angiogenesis, vascular endothelial growth factor and VEGF receptor expression in the BM.
Medinger M; Tichelli A; Bucher C; Halter J; Dirnhofer S; Rovo A; Passweg J; Tzankov A
Bone Marrow Transplant; 2013 May; 48(5):715-21. PubMed ID: 23085826
[TBL] [Abstract][Full Text] [Related]
18. [Change of vascular endothelial growth factor and its receptors expression in acute myeloid leukemia before and after treatment].
Zhang JQ; Wang JK; Li YM
Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):100-2. PubMed ID: 14990052
[TBL] [Abstract][Full Text] [Related]
19. IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia.
Kuett A; Rieger C; Perathoner D; Herold T; Wagner M; Sironi S; Sotlar K; Horny HP; Deniffel C; Drolle H; Fiegl M
Sci Rep; 2015 Dec; 5():18411. PubMed ID: 26674118
[TBL] [Abstract][Full Text] [Related]
20. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
Williams P; Basu S; Garcia-Manero G; Hourigan CS; Oetjen KA; Cortes JE; Ravandi F; Jabbour EJ; Al-Hamal Z; Konopleva M; Ning J; Xiao L; Hidalgo Lopez J; Kornblau SM; Andreeff M; Flores W; Bueso-Ramos C; Blando J; Galera P; Calvo KR; Al-Atrash G; Allison JP; Kantarjian HM; Sharma P; Daver NG
Cancer; 2019 May; 125(9):1470-1481. PubMed ID: 30500073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
